Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fetal pulmonary artery smooth muscle cells are specialized muscle cells found in the walls of pulmonary arteries during fetal development. They are integral to regulating blood flow by contracting and relaxing and also play a role in developmental vascular remodeling. In disease conditions such as pulmonary hypertension, these cells can undergo abnormal proliferation and contribute to pathological thickening of the vessel wall. Fetal PASMCs are distinguishable by the high expression of ACTA2 and display molecular diversity early in lung development. They are not, however, a "target" in the traditional molecular sense, but rather a cell population of interest for developmental biology and vascular disease research[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fetal pulmonary artery smooth muscle cell.